Both ALDH1A3 and treatment with ATRA promoted the expression of RA-inducible genes in MDA-MB-231, MDA-MB-468, and MDA-MB-435 breast cancer cell lines. This evidence concerns the gene ALDH1A3 and breast carcinoma.